Durham R A, Johnson J D, Moore K E, Lookingland K J
Department of Pharmacology and Toxicology, Michigan State University, East Lansing 48824, USA.
Brain Res. 1996 Sep 2;732(1-2):113-20. doi: 10.1016/0006-8993(96)00501-x.
The purpose of the present study was to determine if D2 receptor-mediated activation of hypothalamic tuberoinfundibular dopaminergic (TIDA) neurons occurs via afferent neuronal inhibition of tonically active inhibitory dynorphinergic neurons in the male rat. To this end, the effects of either surgical deafferentation of the mediobasal hypothalamus or administration of a kappa opioid receptor agonist (U-50,488) or antagonist (nor-binaltorphimine (NOR-BNI)) on D2 receptor-mediated activation of TIDA neurons were assessed. For comparison, the activity of mesolimbic DA neurons was also determined in these studies. TIDA and mesolimbic DA neuronal activities were estimated by measuring dopamine synthesis (accumulation of 3,4-dihydroxyphenylalanine (DOPA) following decarboxylase inhibition) and metabolism (concentrations of 3,4-dihydroxyphenylacetic acid (DOPAC)) in terminals of these neurons in the median eminence and nucleus accumbens, respectively. Intraperitoneal administration of the D2 receptor agonist quinelorane caused a dose-dependent increase in DOPAC in the median eminence and a decrease in DOPAC in the nucleus accumbens; surgical deafferentation of the mediobasal hypothalamus prevented the effect of quinelorane in the median eminence, but not the nucleus accumbens. Activation of kappa opioid receptors with U-50,488 had no effect per se, but blocked quinelorane-induced increases in median eminence DOPA. In contrast, U-50,488 had no effect on DOPA in the nucleus accumbens of either vehicle- or quinelorane-treated rats. Blockade of kappa opioid receptors with NOR-BNI increased median eminence DOPA, and prevented the stimulatory effects of quinelorane on dopamine synthesis. Administration of prolactin also increased median eminence DOPA, but did not alter the ability of quinelorane to stimulate dopamine synthesis. Neither NOR-BNI nor prolactin had any effect on DOPA in the nucleus accumbens of vehicle- or quinelorane-treated rats. These results suggest that D2 receptor-mediated activation of TIDA neurons occurs via an afferent neuronal mechanism involving, at least in part, inhibition of tonically active inhibitory dynorphinergic neurons in the male rat.
本研究的目的是确定雄性大鼠中,D2受体介导的下丘脑结节漏斗多巴胺能(TIDA)神经元激活是否通过对持续活跃的抑制性强啡肽能神经元的传入神经抑制而发生。为此,评估了下丘脑中间基底部手术去传入神经、给予κ阿片受体激动剂(U-50,488)或拮抗剂(去甲双丙戊酰胺(NOR-BNI))对D2受体介导的TIDA神经元激活的影响。为作比较,这些研究中还测定了中脑边缘多巴胺能神经元的活性。通过分别测量正中隆起和伏隔核中这些神经元终末的多巴胺合成(脱羧酶抑制后3,4-二羟基苯丙氨酸(DOPA)的积累)和代谢(3,4-二羟基苯乙酸(DOPAC)的浓度)来估计TIDA和中脑边缘多巴胺能神经元的活性。腹腔注射D2受体激动剂喹洛雷导致正中隆起中DOPAC剂量依赖性增加,伏隔核中DOPAC减少;下丘脑中间基底部手术去传入神经可阻止喹洛雷对正中隆起的作用,但对伏隔核无效。用U-50,488激活κ阿片受体本身无作用,但可阻断喹洛雷诱导的正中隆起DOPA增加。相反,U-50,488对用溶剂或喹洛雷处理的大鼠伏隔核中的DOPA均无影响。用NOR-BNI阻断κ阿片受体可增加正中隆起DOPA,并阻止喹洛雷对多巴胺合成的刺激作用。注射催乳素也可增加正中隆起DOPA,但不改变喹洛雷刺激多巴胺合成的能力。NOR-BNI和催乳素对用溶剂或喹洛雷处理的大鼠伏隔核中的DOPA均无任何影响。这些结果表明,D2受体介导的TIDA神经元激活通过一种传入神经机制发生,该机制至少部分涉及对雄性大鼠中持续活跃的抑制性强啡肽能神经元的抑制。